| Product Code: ETC12464238 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Immuno Oncology Assay Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Immuno Oncology Assay Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Immuno Oncology Assay Market - Industry Life Cycle |
3.4 Ireland Immuno Oncology Assay Market - Porter's Five Forces |
3.5 Ireland Immuno Oncology Assay Market Revenues & Volume Share, By Assay Type, 2021 & 2031F |
3.6 Ireland Immuno Oncology Assay Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Immuno Oncology Assay Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Ireland Immuno Oncology Assay Market Revenues & Volume Share, By Technology Used, 2021 & 2031F |
3.9 Ireland Immuno Oncology Assay Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
4 Ireland Immuno Oncology Assay Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing adoption of immuno-oncology therapies in the country |
4.2.3 Technological advancements in immuno-oncology assays |
4.3 Market Restraints |
4.3.1 High cost associated with immuno-oncology assays |
4.3.2 Limited reimbursement policies for immuno-oncology testing in Ireland |
5 Ireland Immuno Oncology Assay Market Trends |
6 Ireland Immuno Oncology Assay Market, By Types |
6.1 Ireland Immuno Oncology Assay Market, By Assay Type |
6.1.1 Overview and Analysis |
6.1.2 Ireland Immuno Oncology Assay Market Revenues & Volume, By Assay Type, 2021 - 2031F |
6.1.3 Ireland Immuno Oncology Assay Market Revenues & Volume, By ELISA-Based Assays, 2021 - 2031F |
6.1.4 Ireland Immuno Oncology Assay Market Revenues & Volume, By PCR-Based Assays, 2021 - 2031F |
6.1.5 Ireland Immuno Oncology Assay Market Revenues & Volume, By Flow Cytometry Assays, 2021 - 2031F |
6.1.6 Ireland Immuno Oncology Assay Market Revenues & Volume, By Western Blot Assays, 2021 - 2031F |
6.1.7 Ireland Immuno Oncology Assay Market Revenues & Volume, By Immunohistochemistry Assays, 2021 - 2031F |
6.2 Ireland Immuno Oncology Assay Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Immuno Oncology Assay Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.3 Ireland Immuno Oncology Assay Market Revenues & Volume, By Tumor Microenvironment Analysis, 2021 - 2031F |
6.2.4 Ireland Immuno Oncology Assay Market Revenues & Volume, By Immune Response Monitoring, 2021 - 2031F |
6.2.5 Ireland Immuno Oncology Assay Market Revenues & Volume, By Drug Development Studies, 2021 - 2031F |
6.2.6 Ireland Immuno Oncology Assay Market Revenues & Volume, By Cancer Biomarker Identification, 2021 - 2031F |
6.3 Ireland Immuno Oncology Assay Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Immuno Oncology Assay Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.3 Ireland Immuno Oncology Assay Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Ireland Immuno Oncology Assay Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.5 Ireland Immuno Oncology Assay Market Revenues & Volume, By Clinical Labs, 2021 - 2031F |
6.3.6 Ireland Immuno Oncology Assay Market Revenues & Volume, By Oncology Research Centers, 2021 - 2031F |
6.4 Ireland Immuno Oncology Assay Market, By Technology Used |
6.4.1 Overview and Analysis |
6.4.2 Ireland Immuno Oncology Assay Market Revenues & Volume, By Multiplex Assays, 2021 - 2031F |
6.4.3 Ireland Immuno Oncology Assay Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.4.4 Ireland Immuno Oncology Assay Market Revenues & Volume, By Flow Cytometry, 2021 - 2031F |
6.4.5 Ireland Immuno Oncology Assay Market Revenues & Volume, By Protein Detection Techniques, 2021 - 2031F |
6.4.6 Ireland Immuno Oncology Assay Market Revenues & Volume, By AI-Assisted Diagnostics, 2021 - 2031F |
6.5 Ireland Immuno Oncology Assay Market, By Sales Channel |
6.5.1 Overview and Analysis |
6.5.2 Ireland Immuno Oncology Assay Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.5.3 Ireland Immuno Oncology Assay Market Revenues & Volume, By Online Sales, 2021 - 2031F |
6.5.4 Ireland Immuno Oncology Assay Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.5.5 Ireland Immuno Oncology Assay Market Revenues & Volume, By Bulk Procurement, 2021 - 2031F |
6.5.6 Ireland Immuno Oncology Assay Market Revenues & Volume, By Research Grants Funding, 2021 - 2031F |
7 Ireland Immuno Oncology Assay Market Import-Export Trade Statistics |
7.1 Ireland Immuno Oncology Assay Market Export to Major Countries |
7.2 Ireland Immuno Oncology Assay Market Imports from Major Countries |
8 Ireland Immuno Oncology Assay Market Key Performance Indicators |
8.1 Adoption rate of immuno-oncology assays in clinical settings |
8.2 Number of partnerships and collaborations for immuno-oncology assay development |
8.3 Rate of regulatory approvals for immuno-oncology assays in Ireland |
9 Ireland Immuno Oncology Assay Market - Opportunity Assessment |
9.1 Ireland Immuno Oncology Assay Market Opportunity Assessment, By Assay Type, 2021 & 2031F |
9.2 Ireland Immuno Oncology Assay Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Immuno Oncology Assay Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Ireland Immuno Oncology Assay Market Opportunity Assessment, By Technology Used, 2021 & 2031F |
9.5 Ireland Immuno Oncology Assay Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
10 Ireland Immuno Oncology Assay Market - Competitive Landscape |
10.1 Ireland Immuno Oncology Assay Market Revenue Share, By Companies, 2024 |
10.2 Ireland Immuno Oncology Assay Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here